Cargando…
Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature
Intravenous immunoglobulins (IVIg) were first introduced in the middle of the twentieth century for the treatment of primary immunodeficiencies. In 1981, Paul Imbach noticed an improvement of immune-mediated thrombocytopenia, in patients receiving IVIg for immunodeficiencies. This opened a new era f...
Autores principales: | Kivity, Shaye, Katz, Uriel, Daniel, Natalie, Nussinovitch, Udi, Papageorgiou, Neophytos, Shoenfeld, Yehuda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101816/ https://www.ncbi.nlm.nih.gov/pubmed/19590986 http://dx.doi.org/10.1007/s12016-009-8155-9 |
Ejemplares similares
-
Hydroxychloroquine: From Malaria to Autoimmunity
por: Ben-Zvi, Ilan, et al.
Publicado: (2011) -
Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review
por: Meridor, Katya, et al.
Publicado: (2021) -
Anti-MDA5 Positive Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease and Correlation between Serum Ferritin Level and Treatment Response
por: Zohar, Daniela Noa, et al.
Publicado: (2020) -
Neuropsychiatric lupus: a mosaic of clinical presentations
por: Kivity, Shaye, et al.
Publicado: (2015) -
The Diagnostic Value of Mir-133a in ST Elevation and Non-ST Elevation Myocardial Infarction: A Meta-Analysis
por: Wexler, Yehuda, et al.
Publicado: (2020)